Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01053845

Acronym

PhyDoNe

Enrollment

Registered

2010-01-21

Start date

2010-04-30

Completion date

2011-05-31

Last updated

2014-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers, Patients Suffering of Peripheral Neuropathic Pain

Keywords

Neuropathic pain

Brief summary

Several studies showed that activity of down inhibitor bundle is weakened in different painful pathologies as the fibromyalgy or the trigeminal nevralgy. The purpose of the protocol is to study the working of down inhibitor bundle at patients suffering of neuropathic pain.

Detailed description

Prospective study with comparison groups

Interventions

OTHERNeuropathic pain

to study the working of down inhibitor bundle at patients suffering of neuropathic pain

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* neuropathic patients group * Patient suffering of peripheral neuropathic pain * 18 years old women or men at least

Exclusion criteria

* • Healthy volunteers * 18 years old women or men at least

Design outcomes

Primary

Measure	Time frame
Comparison of the amplitude of N2P2 waves between healthy volunteers and patients suffering of peripheral neuropathic pain.	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026